Procter & Gamble Health: revenue up 18.0% to ₹376 Cr, net profit up 26.0% to ₹112 Cr
Results · Finvezto · 2 Nov 2026 · Procter & Gamble Health (PGHL)
Results ₹ Cr
| Latest quarter | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 376 | - | +18.0% |
| Operating profit | 152 | - | +26.7% |
| Net profit | 112 | - | +26.0% |
| Operating margin | 40.5% | - | +2.8 pp |
| Net margin | 29.8% | - | +1.9 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Procter & Gamble Health Limited reported sales of Rs 376 crore, up 18% year-on-year, and reported Profit After Tax of Rs 112 crore, up 26% year-on-year, for the second quarter ended September 30, 2026. NSE filing
- Growth was driven by strong brand fundamentals, superior retail execution, positive consumer response to new innovations, and productivity across the value chain. NSE filing
- Revenue was ₹376 Cr, up 18.0% on a year earlier. Finvezto data
Links
NSE filing (PDF) · Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.